The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $66.37

Today's change+0.02 +0.03%
Updated June 2 4:01 PM EDT. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $66.37

Today's change+0.02 +0.03%
Updated June 2 4:01 PM EDT. Delayed by at least 15 minutes.

Baxter International Inc up slightly

Baxter International Inc closed up just (U.S.)$0.02 Tuesday to (U.S.)$66.37. Over the last five days, shares have lost 1.26% and are down 9.44% for the last year to date. This security has underperformed the S&P 500 by 20.18% during the last year.

Key company metrics

  • Open(U.S.) $66.15
  • Previous close(U.S.) $66.35
  • High(U.S.) $66.58
  • Low(U.S.) $66.02
  • Bid / Ask-- / --
  • YTD % change-9.44%
  • Volume4,794,106
  • Average volume (10-day)4,813,464
  • Average volume (1-month)3,911,693
  • Average volume (3-month)3,434,289
  • 52-week range(U.S.) $65.95 to (U.S.) $77.31
  • Beta0.66
  • Trailing P/E19.54×
  • P/E 1 year forward16.74×
  • Forward PEG4.21×
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield3.13%
  • Trailing EPS(U.S.) $3.40
Updated June 2 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.21%

Based on its net profit margin of 11.21%, Baxter International Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.20%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue3,7644,4724,1974,264
Total other revenue--------
Total revenue3,7644,4724,1974,264
Gross profit1,8082,2022,0742,116
Total cost of revenue1,9562,2702,1232,148
Total operating expense3,2783,7253,6193,548
Selling / general / administrative887970921961
Research & development298305292292
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)137180283147
Other operating expenses, total--------
Operating income486747578716
Interest income (expense), net non-operating-35-36-36-47
Gain (loss) on sale of assets--------
Other--------
Income before tax530598586661
Income after tax420524447520
Income tax, total11074139141
Net income430953468520
Total adjustments to net income--------
Net income before extra. items420524447520
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items420524447520
Inc. avail. to common incl. extra. items430953468520
Diluted net income430953468520
Dilution adjustment--------
Diluted weighted average shares548547547548
Diluted EPS excluding extraordinary itemsvalue per share0.770.960.820.95
Dividends per sharevalue per share0.520.520.520.52
Diluted normalized EPSvalue per share0.961.251.211.16